We use cookies for a better user experience. Read our Privacy Policy

I Agree

Epileptic Seizures Treatment Market

Epileptic Seizures Treatment Market (Therapeutic: Midazolam, Alprazolam, Diazepam, Lorazepam, Phenytoin, Fosphenytoin, and Others; Type: Repetitive Seizures, Status Epilepticus, and Others; Route of Administration: Oral/Buccal, Rectal, Nasal, and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Development of New Vaccines and Drugs to Increase Adoption of Existing Epileptic Seizures Treatment

Epilepsy is categorized as a chronic disease of the brain and continues to affect millions of individuals worldwide. Although the prevalence of epilepsy is marginally higher in men compared to women, it affects individuals from all age groups. The prevalence of focal seizures is higher than that of generalized seizures in both, children as well as adults. The prevalence of epileptic seizures is higher in low to middle-income countries due to which, the demand for epileptic seizure treatment is high from developing regions. Some of the major factors responsible for the high prevalence of epileptic seizures in developing regions include acute symptomatic seizures, misdiagnosis, and lack of advanced medical infrastructure.

As epilepsy continues to emerge as a critical cause of mortality and disability around the world, considerable attention has been given to the development and discovery of new epileptic seizures treatment– a factor that is expected to drive the epileptic seizures treatment market during the forecast period. At present, players involved in the current epileptic seizures treatment market are increasingly focusing on reducing the burden of epileptic seizures, improving the access to the existing epileptic seizures treatments, and development of new vaccines and drugs particularly in the low/middle-income countries.

At the back of these factors, along with considerable rise in the number of research and development activities, the global epileptic seizures treatment market is on course to surpass the US$ 1.8 Bn mark by the end of 2030.

Request a sample to get extensive insights into the Epileptic Seizures Treatment Market

Increasing Focus on Providing Seizure-free Life to Fuel Innovations

Over the past few decades, apart from conventional strategies deployed to treat epileptic seizures, including medicine and surgery, a number of alternative treatment options such as deep brain stimulation, vague nerve stimulation, and adoption of ketogenic diet have emerged. As the focus on providing a seizure-free life continues to remain high, considerable improvements have been made in epilepsy diagnosis and treatment. For instance, a range of wearable seizure detectors have been developed that play a key role in tracking the seizure activities of individuals. These devices are likely to minimize unexpected deaths caused by uncontrolled seizures and thereby, increase the demand for epileptic seizures treatment.

Due to the increasing demand for minimally invasive surgeries, a number of new treatment alternatives have gained considerable momentum in recent years. For instance, stereotactic radiosurgery has gradually gained considerable spotlight as a feasible, effective, and an ideal minimally invasive epileptic seizures treatment– a factor that will continue to drive the growth of the global epileptic seizures treatment market in the upcoming years. Furthermore, MRI-guided laser ablation is another treatment alternative that is expected to gain noteworthy adoption in the upcoming years and provide a considerable boost to the growth of the market for epileptic seizures treatment.

While advancements at the surgical front are expected to remain steady throughout the forecast period, considerable progress has been made in the drug-based treatment sphere. A number of researchers and medical experts is increasingly collaborating with each other to improve the current state of epileptic seizures treatment– a factor that is likely to boost market growth.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Adoption of Telemedicine Services to Grow amid COVID-19 Pandemic

The advent of the novel COVID-19 pandemic is projected to have a low impact on the overall growth of the global epileptic seizures treatment market in 2020. Research and development activities in the epileptic seizures treatment market continue to explore the potential risk of contracting the COVID-19 infection among epileptic patients. Some research findings suggest that epileptic patients are at a higher risk of contracting the novel coronavirus disease due to which, the demand for telemedicine services continues to grow within the epileptic seizures treatment market. The increasing demand for telemedicine epileptic seizures treatment during the ongoing pandemic is projected to provide a considerable boost to the growth of the global epileptic seizures treatment market in 2020.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Epileptic Seizures Treatment Market

Analysts’ Viewpoint

The global epileptic seizures treatment market is expected to grow at a moderate CAGR of ~4% during the forecast period. Increasing prevalence of epileptic seizures in patients worldwide, focus on providing a seizure-free life to patients, entry of a number of seizure detection devices, advancements in technology, and focus on research and development. Market players should focus on improving the efficacy of existing treatments and improving the accessibility to current epileptic seizures treatments particularly in developing regions.

Epileptic Seizures Treatment Market: Overview

  • Seizures, which are abnormal movements or behavior due to unusual electrical activity in the brain, are symptoms of epilepsy
  • Epilepsy is a chronic brain disease, which is non-communicable, affecting people of all ages. It causes recurring seizures, which are short episodes of involuntary movement.
  • Several drugs are used for treatment of epileptic seizures; however benzodiazepine class is the most common, which is highly used for the control of seizures
  • Benzodiazepine drugs are more effective therapy for epileptic seizures. These have been developed with less possible side effects and novel route of administration in the past few years.
  • Phenytoin, fosphenytoin, and other ant-epileptic drugs are also used for the treatment of epileptic seizures

Epileptic Seizures Treatment Market: Drivers

  • Rise in prevalence of status epilepticus and acute repetitive seizures is the major factor boosting the growth of the global epileptic seizures treatment market
  • Introduction of novel drug treatments and route of administration for epileptic seizures fuels the growth of the global epileptic seizures treatment market
  • For instance, in January 2020, the U.S. FDA approved Neurilis, Inc.’s Valtoco (diazepam nasal spray) in the U.S. This is a new seizure medicine designed to treat periods of frequent seizures or cluster seizures.
  • Moreover, genetic factors associated with brain malformations & epileptic seizures, and increase in incidence of cardiovascular diseases, head injuries, brain cancer, infections, and substance abuse are the other factors accelerating the growth of the global epileptic seizures treatment market

Market Segmentation: Epileptic Seizures Treatment Market

  • In terms of therapeutic, the global epileptic seizures treatment market has been classified into midazolam, alprazolam, diazepam, lorazepam, phenytoin, fosphenytoin, and others
  • Based on type, the global epileptic seizures treatment market has been divided into repetitive seizures, status epilepticus, and others. The status epilepticus segment has been bifurcated into convulsive status epilepticus and non-convulsive status epilepticus.
  • In terms of route of administration, the global epileptic seizures treatment market has been categorized into oral/buccal, rectal, nasal, and parenteral
  • Based on distribution channel, the global epileptic seizures treatment market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies
  • Each of the epileptic seizures treatment market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and useful insights
  • The epileptic seizures treatment market report provides current and future revenues (US$ Mn) for each of the segments for the period from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Epileptic Seizures Treatment Market

  • In terms of region, the global epileptic seizures treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • North America dominated the global epileptic seizures treatment market in 2019, and the trend is projected to continue during the forecast period
  • The current and future sizes of the epileptic seizures treatment market, in terms of value (US$ Mn), of regional markets and their major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which would help new companies willing to enter the market and existing companies to increase market shares and help in the decision-making process

Major Players

  • The epileptic seizures treatment market report concludes with the company profiles section that includes key information about the major players in the market
  • Key players analyzed in the epileptic seizures treatment market report are
    • Bausch Health Companies, Inc.
    • GlaxoSmithKline plc.
    • UCB S.A.
    • Pfizer, Inc.
    • Apotex, Inc.
    • Alexza Pharmaceuticals, Inc.
    • Neurelis, Inc.
    • Veriton Pharma
  • Each of these players has been profiled in the global epileptic seizures treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Epileptic Seizures Treatment Market – Segmentation

TMR’s study on the global epileptic seizures treatment market includes information divided into four sections: therapeutic, type, route of administration, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these sections of the global epileptic seizures treatment market have been discussed in detail.

Therapeutic

  • Midazolam
  • Alprazolam
  • Diazepam
  • Lorazepam
  • Phenytoin
  • Fosphenytoin
  • Others

Type

  • Repetitive Seizures
  • Status Epilepticus
  • Convulsive Status Epilepticus
  • Non-convulsive Status Epilepticus
  • Others

Route of Administration

  • Oral/Buccal
  • Rectal
  • Nasal
  • Parenteral

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Epileptic Seizures Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of epileptic seizures treatment market?

Epileptic seizures treatment market to reach Valuation Of US$ 1.8 Bn By 2030

What is the anticipated CAGR of the epileptic seizures treatment market in the forecast period?

Epileptic seizures treatment market is projected to expand at a CAGR of ~4% from 2020 to 2030

What are the key driving factors for the growth of the epileptic seizures treatment market?

Epileptic seizures treatment market is driven by increase in patient population with status epilepticus and acute repetitive seizures

Which region is expected to project the highest market share in the global epileptic seizures treatment market?

North America accounted for a major share of the global epileptic seizures treatment market, owing to rise in prevalence of neurological disorders

Who are the key players in the global epileptic seizures treatment market?

Key players in the global epileptic seizures treatment market include Bausch Health Companies, Inc., GlaxoSmithKline plc., UCB S.A., Pfizer, Inc., Apotex, Inc., Alexza Pharmaceuticals, Inc.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Epileptic Seizures Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Epileptic Seizures Treatment Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Pipeline Analysis

5.2. Disease Prevalence & Incidence Rate globally with key countries

5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)

5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Therapeutics

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Therapeutics, 2018–2030

6.3.1. Midazolam

6.3.2. Alprazolam

6.3.3. Diazepam

6.3.4. Lorazepam

6.3.5. Phenytoin

6.3.6. Fosphenytoin

6.3.7. Others

6.4. Market Attractiveness Analysis, by Therapeutics

7. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Type, 2018–2030

7.3.1. Repetitive Seizures

7.3.2. Status Epilepticus

7.3.2.1. Convulsive Status Epilepticus

7.3.2.2. Non-convulsive Status Epilepticus

7.3.3. Others

7.4. Market Attractiveness Analysis, by Type

8. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Route of Administration, 2018–2030

8.3.1. Oral/Buccal

8.3.2. Rectal

8.3.3. Nasal

8.3.4. Parenteral

8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by Distribution Channel, 2018–2030

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness Analysis, by Country/Region

11. North America Epileptic Seizures Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Therapeutics, 2018–2030

11.2.1. Midazolam

11.2.2. Alprazolam

11.2.3. Diazepam

11.2.4. Lorazepam

11.2.5. Phenytoin

11.2.6. Fosphenytoin

11.2.7. Others

11.3. Market Value Forecast, by Type, 2018–2030

11.3.1. Repetitive Seizures

11.3.2. Status Epilepticus

11.3.2.1. Convulsive Status Epilepticus

11.3.2.2. Non-convulsive Status Epilepticus

11.3.3. Others

11.4. Market Value Forecast, by Route of Administration, 2018–2030

11.4.1. Oral/Buccal

11.4.2. Rectal

11.4.3. Nasal

11.4.4. Parenteral

11.5. Market Value Forecast, by Distribution Channel, 2018–2030

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. Market Value Forecast, by Country, 2018–2030

11.6.1. U.S.

11.6.2. Canada

11.7. Market Attractiveness Analysis

11.7.1. By Therapeutics

11.7.2. By Type

11.7.3. By Route of Administration

11.7.4. By Distribution Channel

11.7.5. By Country

12. Europe Epileptic Seizures Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Therapeutics, 2018–2030

12.2.1. Midazolam

12.2.2. Alprazolam

12.2.3. Diazepam

12.2.4. Lorazepam

12.2.5. Phenytoin

12.2.6. Fosphenytoin

12.2.7. Others

12.3. Market Value Forecast, by Type, 2018–2030

12.3.1. Repetitive Seizures

12.3.2. Status Epilepticus

12.3.2.1. Convulsive Status Epilepticus

12.3.2.2. Non-convulsive Status Epilepticus

12.3.3. Others

12.4. Market Value Forecast, by Route of Administration, 2018–2030

12.4.1. Oral/Buccal

12.4.2. Rectal

12.4.3. Nasal

12.4.4. Parenteral

12.5. Market Value Forecast, by Distribution Channel, 2018–2030

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.6. Market Value Forecast, by Country/Sub-region, 2018–2030

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Market Attractiveness Analysis

12.7.1. By Therapeutics

12.7.2. By Type

12.7.3. By Route of Administration

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Epileptic Seizures Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Therapeutics, 2018–2030

13.2.1. Midazolam

13.2.2. Alprazolam

13.2.3. Diazepam

13.2.4. Lorazepam

13.2.5. Phenytoin

13.2.6. Fosphenytoin

13.2.7. Others

13.3. Market Value Forecast, by Type, 2018–2030

13.3.1. Repetitive Seizures

13.3.2. Status Epilepticus

13.3.2.1. Convulsive Status Epilepticus

13.3.2.2. Non-convulsive Status Epilepticus

13.3.3. Others

13.4. Market Value Forecast, by Route of Administration, 2018–2030

13.4.1. Oral/Buccal

13.4.2. Rectal

13.4.3. Nasal

13.4.4. Parenteral

13.5. Market Value Forecast, by Distribution Channel, 2018–2030

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.6. Market Value Forecast, by Country/Sub-region, 2018–2030

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Market Attractiveness Analysis

13.7.1. By Therapeutics

13.7.2. By Type

13.7.3. By Route of Administration

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Epileptic Seizures Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Therapeutics, 2018–2030

14.2.1. Midazolam

14.2.2. Alprazolam

14.2.3. Diazepam

14.2.4. Lorazepam

14.2.5. Phenytoin

14.2.6. Fosphenytoin

14.2.7. Others

14.3. Market Value Forecast, by Type, 2018–2030

14.3.1. Repetitive Seizures

14.3.2. Status Epilepticus

14.3.2.1. Convulsive Status Epilepticus

14.3.2.2. Non-convulsive Status Epilepticus

14.3.3. Others

14.4. Market Value Forecast, by Route of Administration, 2018–2030

14.4.1. Oral/Buccal

14.4.2. Rectal

14.4.3. Nasal

14.4.4. Parenteral

14.5. Market Value Forecast, by Distribution Channel, 2018–2030

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.6. Market Value Forecast, by Country/Sub-region, 2018–2030

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Therapeutics

14.7.2. By Type

14.7.3. By Route of Administration

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region

15. Middle East & Africa Epileptic Seizures Treatment Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast, by Therapeutics, 2018–2030

15.2.1. Midazolam

15.2.2. Alprazolam

15.2.3. Diazepam

15.2.4. Lorazepam

15.2.5. Phenytoin

15.2.6. Fosphenytoin

15.2.7. Others

15.3. Market Value Forecast, by Type, 2018–2030

15.3.1. Repetitive Seizures

15.3.2. Status Epilepticus

15.3.2.1. Convulsive Status Epilepticus

15.3.2.2. Non-convulsive Status Epilepticus

15.3.3. Others

15.4. Market Value Forecast, by Route of Administration, 2018–2030

15.4.1. Oral/Buccal

15.4.2. Rectal

15.4.3. Nasal

15.4.4. Parenteral

15.5. Market Value Forecast, by Distribution Channel, 2018–2030

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.6. Market Value Forecast, by Country/Sub-region, 2018–2030

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Market Attractiveness Analysis

15.7.1. By Therapeutics

15.7.2. By Type

15.7.3. By Route of Administration

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (by tier and size of companies)

16.2. Market Share/Position Analysis, by Company, 2019

16.3. Competitive Business Strategies

16.4. Company Profiles

16.4.1.Bausch Health Companies, Inc.

16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.1.2. Company Financials

16.4.1.3. Growth Strategies

16.4.1.4. SWOT Analysis

16.4.2.GlaxoSmithKline plc.

16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.2.2. Company Financials

16.4.2.3. Growth Strategies

16.4.2.4. SWOT Analysis

16.4.3.UCB S.A.

16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.3.2. Company Financials

16.4.3.3. Growth Strategies

16.4.3.4. SWOT Analysis

16.4.4. Pfizer, Inc.

16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.4.2. Company Financials

16.4.4.3. Growth Strategies

16.4.4.4. SWOT Analysis

16.4.5.Apotex, Inc.

16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.5.2. Company Financials

16.4.5.3. Growth Strategies

16.4.5.4. SWOT Analysis

16.4.6.Alexza Pharmaceuticals, Inc.

16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.6.2. Company Financials

16.4.6.3. Growth Strategies

16.4.6.4. SWOT Analysis

16.4.7. Neurelis, Inc.

16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.7.2. Company Financials

16.4.7.3. Growth Strategies

16.4.7.4. SWOT Analysis

16.4.8.Veriton Pharma

16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.8.2. Company Financials

16.4.8.3. Growth Strategies

16.4.8.4. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis

Table 02: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 03: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 04: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 05: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 06: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 07: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 10: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 11: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 12: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 13: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 14: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 15: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 16: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 17: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 18: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 19: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 20: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 22: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 23: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 24: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 25: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 28: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 29: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 30: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 31: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 32: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 34: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 35: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 36: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 37: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 01: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Epileptic Seizures Treatment Market Value Share, by Therapeutics, 2019

Figure 03: Global Epileptic Seizures Treatment Market Value Share, by Type, 2019

Figure 04: Global Epileptic Seizures Treatment Market Value Share, by Route of Administration 2019

Figure 05: Global Epileptic Seizures Treatment Market Value Share, by Distribution Channel, 2019

Figure 06: Global Epileptic Seizures Treatment Market Value Share, by Region, 2019

Figure 07: Global Epileptic Seizures Treatment Market Value Share, by Status Epilepticus, 2019

Figure 08: Global Epileptic Seizures Treatment Market Value Share Analysis, by Therapeutics, 2019 and 2030

Figure 09: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Midazolam, 2018–2030

Figure 10: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Alprazolam, 2018–2030

Figure 11: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Diazepam, 2018–2030

Figure 12: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Lorazepam, 2018–2030

Figure 13: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Phenytoin, 2018–2030

Figure 14: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Fosphenytoin, 2018–2030

Figure 15: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030

Figure 16: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 17: Global Epileptic Seizures Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 18: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Repetitive Seizures, 2018-2030

Figure 19: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Status Epilepticus, 2018-2030

Figure 20: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030

Figure 21: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 22: Global Epileptic Seizures Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 23: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Oral/Buccal, 2018–2030

Figure 24: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Rectal, 2018–2030

Figure 25: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Nasal, 2018–2030

Figure 26: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Parenteral, 2018–2030

Figure 27: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 28: Global Epileptic Seizures Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 29: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030

Figure 30: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030

Figure 31: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Online Pharmacies, 2018–2030

Figure 32: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 33: Global Epileptic Seizures Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 34: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Region, 2020–2030

Figure 35: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 36: North America Epileptic Seizures Treatment Market Value Share (%), by Country, 2019 and 2030

Figure 37: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country, 2020–2030

Figure 38: North America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 39: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 40: North America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 41: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 42: North America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 43: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 44: North America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 45: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 46: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 47: Europe Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 48: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 49: Europe Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 50: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 51: Europe Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 52: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 53: Europe Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 54: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 55: Europe Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 56: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 57: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 58: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 59: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 61: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 62: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 63: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 64: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 65: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 66: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 67: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 68: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 69: Latin America Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 70: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 71: Latin America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 72: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 73: Latin America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 74: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 75: Latin America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 76: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 77: Latin America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 78: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 79: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 80: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 81: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 82: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 83: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 84: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 85: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 86: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 87: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 88: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 89: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 90: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

731

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved